Skip to main content
. 2020 May 16;85:153242. doi: 10.1016/j.phymed.2020.153242

Table 3.

Comparison of the adverse events in the full analysis set

Adverse events Treatment group Control group p value
Total 65 (45.8%) 77 (54.2%) 0.154
Abnormal liver function 32(22.5%) 32(22.5%) 1.000
Renal dysfunction 8 (5.6%) 11 (7.7%) 0.476
Headache 1 (0.7%) 1 (0.7%) 1.000
Nausea 6 (4.2%) 5 (3.5%) 0.758
Vomiting 2 (1.4%) 3 (2.1%) 0.652
Diarrhea 8 (5.6%) 19 (13.4%) 0.026
Loss of appetite 8 (5.6%) 6 (4.2%) 0.584